Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Interventional × Cachexia × Clear all

Phase

Status

Sponsor Class

OTHER 66 INDUSTRY 29 NIH 2 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 39 Colorectal Neoplasms 31 Neoplasms 29 Lung Neoplasms 18 Breast Neoplasms 11 Colonic Neoplasms 10 Colonic Polyps 9 Rare Diseases 8 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Hepatocellular 6 Ovarian Neoplasms 5 Motor Activity 5 Heart Failure 5 Urinary Bladder Neoplasms 4 Pulmonary Disease, Chronic Obstructive 4 Lung Diseases 4 Liver Neoplasms 4 Fibrosis 4 Esophageal Neoplasms 4 Barrett Esophagus 4 Rectal Neoplasms 3 Obesity 3 Neurologic Manifestations 3 Neoplasms by Site 3 Neoplasm Metastasis 3 Myasthenia Gravis 3 Mental Disorders 3 Lymphoma 3 Leukemia 3 Hematologic Neoplasms 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01505764 2018-07-17

The Role of Ghrelin in Cancer Cachexia

VA Office of Research and Development

Phase 2 Terminated

10 enrolled 20 charts

Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡